SPOTLIGHT: Argos, J&J make a deal

Therakos, a Johnson & Johnson company, has struck a licensing deal with Argos Therapeutics. Therakos gains Arros' technology related to part of the immune system known as regulatory T cells. Financial details were not disclosed. Release